Skip to Main Content

Paper Details

The <i>CHEK2</i> Variant C.349A&gt;G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.
Cancers (Basel)
14
2020
C.349A, CHEK2, CHEK2 Variant, CHEK2 c.349A, CHEK2 recurrent variant, PrCa, Prostate Cancer, c.349A, c.349A>G, cancer, cancer predisposing genes, conserved region, familial/hereditary prostate cancer, patients, prostate cancer
Author NameAffiliation
Douglas F EastonThe Institute of Cancer Research
Douglas F EastonRoyal Marsden NHS Foundation Trust
Zsofia Kote-JaraiThe Institute of Cancer Research
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Johanna SchleutkerTurku University Hospital
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Johanna SchleutkerTurku University Hospital
Henrik Gr??nbergKarolinska Institute
Henrik Gr??nbergKarolinska Institute
David E NealUniversity of Oxford, John Radcliffe Hospital
David E NealUniversity of Cambridge, Addenbrooke's Hospital
David E NealCambridge Research Institute
Børge G NordestgaardUniversity of Copenhagen
Børge G NordestgaardHerlev and Gentofte Hospital, Copenhagen University Hospital
Demetrius AlbanesNational Cancer Institute
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Ruth C TravisUniversity of Oxford
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordSchool of Public Health, University of Washington
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordSchool of Public Health, University of Washington
Lorelei A MucciHarvard T. H. Chan School of Public Health
Catharine M L WestUniversity of Manchester, The Christie Hospital NHS Foundation Trust
Sune F NielsenUniversity of Copenhagen
Sune F NielsenHerlev and Gentofte Hospital, Copenhagen University Hospital
Sonja I BerndtNational Cancer Institute
Cezary CybulskiInternational Hereditary Cancer Center, Pomeranian Medical University
Sue A InglesKeck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Barry S RosensteinIcahn School of Medicine at Mount Sinai
Barry S RosensteinIcahn School of Medicine at Mount Sinai
Fredrik WiklundKarolinska Institute
Kathryn L PenneyBrigham and Women's Hospital/Harvard Medical School
Esther M JohnStanford Cancer Institute, Stanford University School of Medicine
Monique J RoobolErasmus University Medical Center
  • 1 - 35

Datasets